| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/KEM169 |
| P698 | PubMed publication ID | 17704521 |
| P50 | author | George D. Kitas | Q37831495 |
| Antonios Stavropoulos-Kalinoglou | Q54268921 | ||
| Moses Elisaf | Q56966508 | ||
| P2093 | author name string | Douglas KM | |
| Milionis HJ | |||
| Nightingale P | |||
| Metsios GS | |||
| Kita MD | |||
| Panoulas VF | |||
| Tselios AL | |||
| P433 | issue | 9 | |
| P921 | main subject | hypertension | Q95566669 |
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 1477-1482 | |
| P577 | publication date | 2007-08-17 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis | |
| P478 | volume | 46 |
| Q84281565 | A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis |
| Q92670725 | Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker? |
| Q37962792 | Arterial dysfunction in patients with rheumatoid arthritis and the consumption of daily fruits and daily vegetables. |
| Q59303860 | Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white c |
| Q38846131 | Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes |
| Q89970218 | Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry |
| Q48263351 | Association between urinary sodium and potassium excretion and blood pressure and inflammation in patients with rheumatoid arthritis |
| Q40084891 | Association of Asthma with Rheumatoid Arthritis: A Population-Based Case-Control Study |
| Q96132125 | Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis |
| Q38365624 | Atherosclerotic vascular disease in the autoimmune rheumatologic patient |
| Q64232439 | Autoimmune Disease-Associated Hypertension |
| Q91776881 | Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions |
| Q58609925 | Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis |
| Q47098082 | Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis |
| Q92464675 | Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment |
| Q38568465 | Cardiovascular comorbidity in rheumatic diseases |
| Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
| Q34495257 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q37808570 | Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications |
| Q35929968 | Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results |
| Q99240510 | Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout |
| Q38813397 | Cardiovascular risk in patients with rheumatoid arthritis |
| Q26744334 | Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps |
| Q36320021 | Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis |
| Q37691111 | Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study. |
| Q37765185 | Constitutional symptoms at the onset of rheumatoid arthritis and subsequent arterial stiffness. |
| Q90415381 | Correlates of sedentary behaviour and light physical activity in people living with rheumatoid arthritis: protocol for a longitudinal study |
| Q46796548 | Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors |
| Q36593810 | Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process |
| Q35557984 | Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis. |
| Q35029916 | Dyslipidaemia in rheumatological autoimmune diseases |
| Q87641476 | Effect of hypertension on echocardiographic parameters in rheumatoid arthritis |
| Q37883018 | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. |
| Q57299625 | Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project |
| Q88455843 | Frequency and Predictors of Communication About High Blood Pressure in Rheumatoid Arthritis Visits |
| Q38954601 | Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism |
| Q54060732 | Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. |
| Q94550332 | Hypertension in rheumatic diseases: prevalence, awareness, treatment, and control rates according to current hypertension guidelines |
| Q42366660 | Immunological consequences of ageing microvascular hemodynamic changes in view of cancer development and treatment |
| Q34724972 | Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care |
| Q92355252 | Impaired renal functions in Pakistani cohort of rheumatoid arthritis |
| Q39328180 | Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study |
| Q37281848 | Inflammation and hypertension in rheumatoid arthritis |
| Q46598130 | Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients |
| Q33642021 | Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction |
| Q90171583 | Intracerebral Hemorrhage in a Patient with Untreated Rheumatoid Arthritis: Case Report and Literature Review |
| Q37307983 | Is hypertension an immunologic disease? |
| Q84958818 | Is the prevalence of arterial hypertension in rheumatoid arthritis and osteoarthritis associated with disease? |
| Q34917991 | Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis |
| Q37704498 | Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial. |
| Q37058791 | Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion |
| Q39210337 | Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches |
| Q37350896 | Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study |
| Q41718646 | Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study. |
| Q39882466 | Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. |
| Q88347952 | Nocturnal blood pressure dipping is similar in rheumatoid arthritis patients as compared to a normal population |
| Q35320084 | Non-steroidal anti-inflammatory drug (NSAID) related inhibition of aldosterone glucuronidation and arterial dysfunction in patients with rheumatoid arthritis: a cross-sectional clinical study |
| Q37801496 | Obesity in rheumatoid arthritis |
| Q36245670 | Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study |
| Q41464826 | Prevalence of Asymptomatic Arterial Hypertension and Its Correlation with Inflammatory Activity in Early Rheumatoid Arthritis. |
| Q36511541 | Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis |
| Q26744032 | Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same? |
| Q89121860 | Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis |
| Q37858434 | Relationship between arterial dysfunction and extra-articular features in patients with rheumatoid arthritis. |
| Q38169961 | Relationship of EQ-5D quality of life with the presence of co-morbidity and extra-articular features in patients with rheumatoid arthritis. |
| Q38149252 | Rheumatoid arthritis and cardiovascular disease |
| Q82076745 | Rheumatoid arthritis and cardiovascular disease |
| Q36812587 | Rheumatoid arthritis and cardiovascular disease: an update on treatment issues |
| Q33675569 | Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbidities |
| Q47817154 | Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries |
| Q37774545 | Rheumatoid cachexia and cardiovascular disease. |
| Q39361426 | Role of Inflammatory Diseases in Hypertension |
| Q33602177 | Sedentary behaviour is associated with increased long-term cardiovascular risk in patients with rheumatoid arthritis independently of moderate-to-vigorous physical activity |
| Q40065441 | Sex and Cardiovascular Involvement in Inflammatory Joint Diseases |
| Q36116344 | Structural and morphological changes in the eyes of arterial hypertensive patients with and without anti-CCP-positive rheumatoid arthritis |
| Q36205262 | Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study |
| Q89314644 | Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases |
| Q90159347 | Temporal Hemodynamic Changes in a Female Mouse Model of Systemic Lupus Erythematosus |
| Q33600869 | The effect of quercetin on plasma oxidative status, C-reactive protein and blood pressure in women with rheumatoid arthritis |
| Q35092457 | The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. |
| Q33547329 | The role of endothelial function and its assessment in rheumatoid arthritis. |
| Q36907676 | The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study. |
| Q37770789 | Tocilizumab: therapy and safety management |
| Q33871929 | Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis. |
| Q26822912 | Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis |
| Q37723293 | Vascular function and inflammation in rheumatoid arthritis: the role of physical activity |
| Q33697879 | Why do people with rheumatoid arthritis still die prematurely? |
| Q87387286 | [Treatment of cardiovascular risk factors] |
Search more.